The global Radiation, Detection, Monitoring & Safety Market, valued at US$3,132.2million in 2023, is forecasted to grow at a ...

Detailed price information for Ivanhoe Mines Ltd (IVN-T) from The Globe and Mail including charting and trades.

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Good morning, ladies and gentlemen, welcome to Vivo’s First Quarter 2025 Earnings Call. This conference is being recorded, and a replay will be available at the company’s website at ri.telefonica.com.

May 14, 2025) - Tower Resources Ltd. (TSXV: TWR) (" Tower " or the " Company ") announces it has initiated the spring 2025 diamond drill program to test the high-grade Blue Sky, Thunder and Thunder ...